Your browser doesn't support javascript.
loading
An integrated approach to uncover anti-tumor active materials of Curcumae Rhizoma-Sparganii Rhizoma based on spectrum-effect relationship, molecular docking, and ADME evaluation.
Liu, Xiao-Yun; Chang, Yan-Li; Wang, Xiu-Huan; Wang, Yu; Ren, Xue-Yang; Ma, Jia-Mu; Yu, A-Xiang; Wei, Jing; Fan, Qi-Qi; Dong, Ying; Song, Ruo-Lan; Yao, Jian-Ling; Shan, Dong-Jie; She, Gai-Mei.
Afiliação
  • Liu XY; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: liuxiao
  • Chang YL; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: changya
  • Wang XH; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: wangxiu
  • Wang Y; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: wangyu1
  • Ren XY; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: renxuey
  • Ma JM; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: majiamu
  • Yu AX; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: yuaxian
  • Wei J; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: Radiant
  • Fan QQ; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: ki_ki19
  • Dong Y; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: 1532822
  • Song RL; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: songruo
  • Yao JL; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: 1880137
  • Shan DJ; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: bucmsha
  • She GM; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China; Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing, 102488, China. Electronic address: shegaim
J Ethnopharmacol ; 280: 114439, 2021 Nov 15.
Article em En | MEDLINE | ID: mdl-34293455
ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE Curcumae Rhizoma-Sparganii Rhizoma (CR-SR), an ancient and classical herbal couple, has been extensively used for tumor treatment in clinic of traditional Chinese medicines (TCMs). AIM OF THE STUDY The study aimed to uncover the anti-tumor active materials of CR-SR water decoction (CRSR = 11) via an integrated approach of spectrum-effect relationship, molecular docking, and ADME evaluation. MATERIALS AND

METHODS:

The anti-tumor activities toward A549, HepG2, Hela, BGC-823, and MCF-7 cells of the different polar elution fractions (DPEFs) of CR, SR, and CR-SR were determined by Cell Counting Kit-8 (CCK-8) assay. Likewise, the DPEFs' combinations of CR and SR were also tested. The chemical fingerprints of these fractions were profiled by HPLC. Meanwhile, HPLC-ESI-Q-TOF-MS/MS was applied for the identification of chemical components. The main effect-related compounds were screened out by spectrum-effect relationship and molecular docking method. The oral bioavailability and druggability of these active components were subsequently evaluated. Finally, five monomeric compounds were validated experimentally using HepG2 cells.

RESULTS:

The 80% ethanol elution fraction of CR, SR, and CR-SR showed strong anti-tumor effects toward five cells. Also, the combinations with the 80% ethanol elution fraction of CR and SR showed stronger tumor inhibition effects among the DPEFs' combinations of CR and SR. By spectrum-effect relationship, HPLC-MS, and molecular docking analysis, 24 main effect-related compounds seemed to have potential anti-tumor effects. ADME evaluation showed rutin performed low oral bioavailability and druggability. Therefore, we suppose that 23 compounds (including 4 unknown compounds) are the primary anti-tumor active components of CR-SR water decoction. Among them, zederone, curcumol, chlorogenic acid, calycosin, and curcumenol were validated successfully with good tumor inhibition effects.

CONCLUSIONS:

In summary, this study demonstrated that the multi-components of CR-SR contribute to its anti-tumor effects. It established a rapid and useful strategy to explore the active material basis of traditional Chinese herbal couples with a multi-technology integrated approach in practice, including chromatography, mass spectrometry, machine algorithm models, online databases, and in vitro cell experiments.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Raízes de Plantas / Curcuma / Typhaceae / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Raízes de Plantas / Curcuma / Typhaceae / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article